Display options
Share it on

Can J Cardiol. 2006 Apr;22(5):399-404. doi: 10.1016/s0828-282x(06)70925-4.

Trends in five-year survival of patients discharged after acute myocardial infarction.

The Canadian journal of cardiology

Iqbal R Bata, Ronald D Gregor, Hermann K Wolf, Brenda Brownell

Affiliations

  1. Department of Medicine, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada.

PMID: 16639475 PMCID: PMC2560535 DOI: 10.1016/s0828-282x(06)70925-4

Abstract

BACKGROUND: It has previously been shown that the increased use of therapeutic intervention may not reduce patient fatality if there is a simultaneous increase in case severity. The present study was designed to extend the relationship between case severity and therapeutic interventions to long-term survival in the same study population.

OBJECTIVE: To compare five-year survival of patients discharged after acute myocardial infarction from 1984 to 1988 and from 1989 to 1993, and to evaluate possible reasons for survival differences.

METHODS: The present study was population-based. Survival time was determined by record linkage into the Canadian Mortality Database. Association of five-year survival with patient characteristics, in-hospital treatment and discharge medications was assessed by logistical regression analysis. Case severity was calculated as the probability of death within five years, given the patient profile and excluding any interventions.

RESULTS: Between the two study periods, most patient characteristics and treatment intensity changed, but case severity for the study population remained constant. Five-year survival improved from 74.8% to 79.2% (P(chi2)=0.001). The improvement was adequately described by the combination of changes in patient profile and treatment without residual period effect (P(goodness-of-fit)=0.752). The treatments significantly associated with five-year survival were coronary artery bypass graft surgery (OR 2.74; 95% CI 1.86 to 4.05), percutaneous coronary intervention (OR 2.63; 95% CI 1.67 to 4.14) and thrombolysis (OR 1.98; 95% CI 1.50 to 2.62) during admission, as well as acetylsalicylic acid (OR 1.39; 95% CI 1.15 to 1.68) or beta-blocker (OR 1.60; 95% CI 1.34 to 1.92) prescription at discharge.

CONCLUSIONS: Changes in patient profile did not affect long-term prognosis; instead, treatment modalities accounted for the observed improvement in five-year survival.

References

  1. Eur Heart J. 2005 Jan;26(1):18-26 - PubMed
  2. Circulation. 2002 Oct 29;106(18):2309-14 - PubMed
  3. CMAJ. 1991 Apr 15;144(8):1015-25 - PubMed
  4. Comput Biol Med. 1983;13(3):157-69 - PubMed
  5. Can J Public Health. 1993 May-Jun;84(3):201-4 - PubMed
  6. Heart. 2004 Dec;90(12):1404-10 - PubMed
  7. Circulation. 1994 Jul;90(1):583-612 - PubMed
  8. Am J Cardiol. 2002 Aug 15;90(4):358-63 - PubMed
  9. J Clin Epidemiol. 1992 Apr;45(4):419-28 - PubMed
  10. Can J Cardiol. 1995 Jun;11(6):477-86 - PubMed
  11. Int J Epidemiol. 1973 Autumn;2(3):257-63 - PubMed
  12. Res Nurs Health. 2002 Feb;25(1):76-84 - PubMed
  13. J Clin Epidemiol. 2001 Dec;54(12):1244-50 - PubMed
  14. J Intern Med. 2000 Nov;248(5):425-34 - PubMed
  15. Lancet. 1993 Oct 2;342(8875):821-8 - PubMed
  16. N Engl J Med. 1992 Sep 3;327(10):669-77 - PubMed
  17. Comput Biomed Res. 1981 Aug;14(4):327-40 - PubMed
  18. Can J Cardiol. 1998 Aug;14(8):1017-24 - PubMed
  19. Can J Cardiol. 2004 Feb;20(2):213-9 - PubMed
  20. J Am Coll Cardiol. 1991 Sep;18(3):698-706 - PubMed
  21. Can J Cardiol. 2000 May;16(5):589-95 - PubMed
  22. Can J Cardiol. 2000 May;16(5):596-603 - PubMed
  23. Can J Public Health. 1989 Jan-Feb;80(1):54-7 - PubMed
  24. Eur Heart J. 2000 Nov;21(22):1833-40 - PubMed
  25. J Am Coll Cardiol. 1999 May;33(6):1533-9 - PubMed
  26. Circulation. 1999 Aug 10;100(6):599-607 - PubMed

MeSH terms

Publication Types